Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Bhel 193.60 2.27
Tata Stl 425.50 0.26
State Ba 2095.00 1.47
Hindalco 143.80 0.62
Wipro Lt 523.00 0.38
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Merck Limited
Merck Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:500126NSE:MERCKBloomberg:EMER@INReuters:MERK.BO
Market Lot: 1Face Value: 10ISIN Demat: INE199A01012
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
13-JAN-14 Reliance Mutual Fund A/C Reliance Pharma Fund picked 1.54% stake in Merck for Rs 140.81 million today. It purchased 0.25 million shares at a price of Rs 549 at the NSE. 15-SEP-11 Credit rating agency, ICRA has reaffirmed AA to Rs 267.5 million fund based and Rs 47.5 million non-fund based bank limits of Merck (Merck). The long term rating has been assigned stable outlook. 25-APR-11 Merck is a global pharmaceutical and chemical compa...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Merck standalone quarterly profit falls 17.22%   -IRIS 30-Jul-13
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)31-Dec-2013 (12)31-Dec-2012 (12)31-Dec-2011 (12)
Net sales 7729.626580.705575.71
Other Income214.48201.96463.21
Total Income7944.106782.666038.92
Cost of goods sold7209.125817.875171.71
OPBDIT734.98964.79867.21
PAT558.76784.01636.80
Gross Block---
Equity capital165.99165.99165.99
EPS (Rs.)33.6647.2338.36
DPS (Rs.)---
BV (Rs.)---
P/E range (x)15.53 - 20.4711.75 - 15.1214.42 - 19.81
Debt / Equity (x)---
Operating margin (% of OI) 9.314.214.4
Net margin (% of OI) 7.011.610.5
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Shiv Sagar Estate A
Dr. Annie Besant Road
Worli
Mumbai
Maharashtra-400 018
PHONE
(022) 6660 9173
FAX
(022) 2495 0307
 
Board of Directors
Board Meetings
Date Purpose
30-APR-14 Quarterly Results
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer